About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Antonio | 3,574 Studies Near You

Clinical TrialsSan Antonio

Clinical Trials in San Antonio

Discover 3,574 clinical trials near San Antonio, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3421-3440 of 3,574 trials

CompletedTreating Thought Problems in Patients With SchizophreniaThis study will compare Cognitive Adaptation Training (CAT) to minimal schizophrenia treatment.NCT00051740·San Antonio, Texas RecruitingSARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR ProjectThis is a multicenter prospective observational study lead by the FIL on sarcopenia and sGA as possible predictors of efficacy and toxicity outcomes in patients undergoing CAR-T…NCT06156774·Alessandria and 20 others

Find Trials by Condition in San Antonio

Breast Cancerin San Antonio Lung Cancerin San Antonio Prostate Cancerin San Antonio Colorectal Cancerin San Antonio Melanomain San Antonio Leukemiain San Antonio Lymphomain San Antonio Pancreatic Cancerin San Antonio Ovarian Cancerin San Antonio Brain Cancerin San Antonio

Data from ClinicalTrials.govTerms

CompletedFilgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's DiseaseThe primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active Crohn's…NCT02914561·Dothan, Alabama and 512 others

TerminatedCurvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market EvaluationProspective, single arm, post-market evaluation to evaluate the use and performance of the IM Implant in a post market setting.NCT05606042·Springfield, Illinois and 5 others

CompletedCSP #512 - Options in Management With Anti-RetroviralsThis 'pragmatic' trial is a 2X2 open randomized study of patients in advanced HIV disease who have failed on conventional Highly Active Antiretroviral Therapy (HAART) regimens…NCT00050089·Phoenix, Arizona and 29 others

CompletedProspective Observational Epidemiologic Study of Maraviroc's SafetyThe study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized…NCT00665561·Hobson City, Alabama and 268 others

CompletedCardiac Rhythm Monitoring After Acute Decompensation for Heart FailureThe CARRYING ON for heart failure (HF) study is a national, prospective, post market interventional, multi-center, open-label, pilot trial.The purpose of the study is to assess a…NCT01216670·Alessandria, Alessandria and 3 others

CompletedVorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal CancerThis will be a randomized phase II clinical trial of patients with histologic documentation of metastatic colorectal cancer, who have received local and currently approved…NCT02316340·San Antonio, Texas

RecruitingA Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)The purpose of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung Cancer and PD-L1 ≥…NCT07361510·Daphne, Alabama and 283 others

CompletedRisk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaThis research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia.NCT01142427·Birmingham, Alabama and 243 others

RecruitingA Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusThis study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood sugar control while taking a…NCT07340320·Birmingham, Alabama and 47 others

CompletedA Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)This study is designed to describe the safety, tolerability, and immunogenicity of V114 in children with sickle cell disease.NCT03731182·Wilmington, Delaware and 18 others

CompletedNon-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent LymphomaThe promising activity of Bortezomib as single agent in low grade lymphoma patients in small studies has led to a number of larger multicenter trials with Bortezomib in…NCT00509379·Tricase, Lecce and 21 others

Active not recruitingBomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)The purpose of this study is to evaluate the efficacy and safety of bomedemstat compared with hydroxyurea in cytoreductive therapy naïve essential thrombocythemia (ET)…NCT06456346·Glendale, Arizona and 170 others

CompletedAn Extension Study in Participants With Moderate to Severe Rheumatoid ArthritisThe purpose of this study is to investigate the long-term safety and any side effects of baricitinib in participants who have completed a previous baricitinib rheumatoid arthritis…NCT01885078·Glendale, Arizona and 407 others

RecruitingSafety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic FeverThe goal of this clinical trial is to assess the safety, tolerability and immunogenicity of three dosage levels, and a single or two-dose administration regimen, of the…NCT06799013·San Antonio, Texas

CompletedClinical Outcomes Utilizing Revascularization and Aggressive Drug EvaluationPCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause…NCT00007657·Scottsdale, Arizona and 47 others

TerminatedStudy of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Study CX-659-401 is a multicenter, open-label, phase 2 study of mivavotinib to evaluate the single-agent activity of mivavotinib in patients with relapsed/refractory non-GCB/ABC…NCT05319028·Evanston, Illinois and 6 others

CompletedARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)The primary objective is to determine the effect of ambrisentan on exercise capacity in subjects with PAH.NCT00091598·Phoenix, Arizona and 45 others

WithdrawnAdjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer PatientsThis study aims to examine the use of high-intensity interval training (HIIT) and resistance training on docetaxel chemotherapy tolerability and toxicity in metastatic prostate…NCT05156372·San Antonio, Texas

PreviousPage 172 of 179Next

Diabetes

in San Antonio

Heart Diseasein San Antonio